JUN 12, 2018 3:11 PM PDT

Loss of Brain Lesions may Indicate Worsening MS

WRITTEN BY: Carmen Leitch

Doctors that monitor patients with multiple sclerosis (MS) have been using magnetic resonance imaging (MRI) to help treat the disease and determine outcomes.  Expanding brain lesions are thought to indicate progressive, worsening MS. However, scientists at the University of Buffalo have now found that the disappearance of these lesions as they waste away into cerebrospinal fluid (CSF) is probably an indicator of disability.

Representative example of an atrophied ('disintegrating') lesion. Top row shows baseline MRI images, and bottom row shows follow-up MRI images. The magenta region in the bottom right panel shows the part of the original lesion (top) that has disintegrated into cerebrospinal fluid over the intervening period. Nearly 20 percent of the lesion was lost over time. / Credit: Michael G. Dwyer

Researchers completed this study of 192 patients over five years and reported it in the Journal of Neuroimaging. Their findings were similar to results from a ten-year study involving 176 patients, presented at this year’s annual meeting of the American Academy of Neurology (AAN).

"Using the appearance of new brain lesions and the enlargement of existing ones as the indicator of disease progression, there was no sign of who would develop disability during five or ten years of follow-up, but when we used the amount of brain lesion volume that had atrophied, we could predict within the first six months who would develop disability progression over long-term follow-up,” noted Robert Zivadinov, MD, PhD, senior author of the five year project and first author of the ten-year study. Zivadinov is a professor of neurology and director of the Buffalo Neuroimaging Analysis Center (BNAC) in the Jacobs School.

Brain lesions are seen as a bad sign in general and can accompany disease or trauma. These lesions are found in MS patients, who routinely receive MRI scans as part of their care. Loss of the lesions might be interpreted as a positive sign, noted Zivadinov. In MS, the protective sheath around neurons is lost, so new growth of those sheaths could indicate repair.

In this work, the investigators looked at lesions that were not replaced by neurons with new sheaths, but instead, neurons that were replaced by CSF. "How do we know the lesions have disappeared?" queried Zivadinov. "Because where there was brain lesion tissue before, there now is just fluid."

"The big news here is that we did the opposite of what has been done in the last 40 years," noted Michael G. Dwyer, Ph.D., assistant professor of neurology and bioinformatics in the Jacobs School and first author on the five-year study in the Journal of Neuroimaging. "Instead of looking at new brain lesions, we looked at the phenomenon of brain lesions disappearing into the cerebrospinal fluid."

The researchers linked a decrease in the size of lesions with a greater number of physical problems in MS patients. "We didn't find a correlation between people who developed more or larger lesions and developed increased disability," said Dwyer, "but we did find that atrophy of lesion volume predicted the development of more physical disability."

The biggest number of lesions were seen in those with a type of MS called relapsing-remitting, but in the most severe class, progressive MS, there was the fastest rate of atrophy in brain lesions. That could make imaging those lesions a critical biomarker for types of MS.

"Paradoxically, we see that lesion volume goes up in the initial phases of the disease and then plateaus in the later stages," said Zivadinov. "When the lesions decrease over time, it's not because the patient lesions are healing but because many of these lesions are disappearing, turning into cerebrospinal fluid."

The scientists also found that atrophy in brain lesions was a better way to predict disability than atrophy in the entire brain, which is the most common way to assess MS.
 
"Our data suggest that atrophied lesions are not a small, secondary phenomenon in MS, and instead indicate that they may play an increasingly important role in predicting who will develop a more severe and progressive disease," Zivadinov concluded.

 

Sources: AAAS/Eurekalert! Via University of Buffalo, Journal of Neuroimaging

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 15, 2019
Genetics & Genomics
DEC 15, 2019
Making T-Cell Therapy Even More Effective
Curated w/video - CRISPR/Cas9 deletion of an enzyme resulted in longer lasting, more robust therapy....
DEC 18, 2019
Genetics & Genomics
DEC 18, 2019
Learning More About The Genetic Adaptations Cancer Relies On
Cancer cells can adapt to mutations in the genome that might kill the cells by altering the activity of their genes....
DEC 22, 2019
Cell & Molecular Biology
DEC 22, 2019
Learning More About Cell Dynamics with Holo-Tomographic Microscopy
A new microscopy technique called holo-tomographic microscopy can generate 3D images and does not require labeling....
JAN 28, 2020
Cell & Molecular Biology
JAN 28, 2020
A Rare Genetic Disorder is Effectively Treated With Modified Stem Cells
A clinical trial used stem cell gene therapy to treat a rare genetic disorder called X-CGD. Image credit: UCLA Broad Stem Cell Research Center/Nature Medicine...
FEB 03, 2020
Cell & Molecular Biology
FEB 03, 2020
Brain Organoids May Not be Living Up to the Hype
Cells can be grown in special ways to create three-dimensional, miniature models of organs. But how good are they?...
FEB 23, 2020
Microbiology
FEB 23, 2020
Using Cranberries and Citrus to Remove Viruses From Food
Noroviruses can contaminate fresh produce and in developed nations, they are the most common cause of gastroenteritis....
Loading Comments...